Securities Registration: Employee Benefit Plan (s-8)
March 16 2017 - 4:52PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on March 16, 2017
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
S-8
REGISTRATION STATEMENT
Under
The
Securities Act of 1933
OMEROS CORPORATION
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Washington
|
|
|
|
91-1663741
|
(State or other jurisdiction of
incorporation or organization)
|
|
|
|
(I.R.S. Employer
Identification Number)
|
201 Elliott Avenue West
Seattle, Washington 98119
(Address of principal executive offices) (Zip code)
2008 Equity
Incentive Plan
(Full title of the plan)
Gregory A.
Demopulos, M.D.
President, Chief Executive Officer and
Chairman of the Board of Directors
Omeros Corporation
201
Elliott Avenue West
Seattle, Washington 98119
(Name and address of agent for service)
(206)
676-5000
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☒
|
|
|
|
|
Non-accelerated
filer
|
|
☐ (Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
☐
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of Securities
to be Registered
|
|
Amount
to be
Registered
|
|
Proposed
Maximum
Offering
Price
Per Share
|
|
Proposed
Maximum
Aggregate
Offering Price
|
|
Amount of
Registration Fee
|
Common Stock, $0.01 par value per share
|
|
1,785,714
(1)
|
|
$11.35
(2)
|
|
$20,258,925
(2)
|
|
$2,348.01
|
|
|
(1)
|
Represents additional shares of Omeros Corporation (the Registrant) common stock, par value $0.01 per share (the Common Stock), available for issuance under the 2008 Equity Incentive Plan as a
result of provisions in that plan that allow for automatic annual increases of the number of shares of Common Stock available for issuance. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act),
this Registration Statement shall also cover any additional shares of Common Stock that become issuable under the 2008 Equity Incentive Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without
receipt of consideration that increases the number of the Registrants outstanding shares of Common Stock.
|
(2)
|
The offering price is computed in accordance with Rule 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee based upon the price of $11.35 per share, which was the
average of the high and low prices of the Common Stock of the Registrant as reported on The Nasdaq Global Market on March 13, 2017.
|
OMEROS CORPORATION
REGISTRATION OF ADDITIONAL SECURITIES
PURSUANT TO GENERAL INSTRUCTION E
This Registration Statement registers additional shares of our Common Stock to be issued pursuant to our 2008 Equity Incentive Plan.
Accordingly, unless noted herein, the contents of the previous registration statements on
Form S-8
filed with the Securities and Exchange Commission (the SEC) on October 29, 2009 (File
No. 333-162732),
April 1, 2010 (File
No. 333-165861),
March 17, 2011 (File
No. 333-172905),
March 19,
2012 (File
No. 333-180216),
March 18, 2013 (File
No. 333-187344),
March 19, 2014 (File
No. 333-194693),
March 16, 2015 (File
No. 333-202788)
and March 15, 2016 (File
No. 333-210219)
are incorporated by reference into this Registration Statement pursuant
to General Instruction E of
Form S-8.
Item 3.
|
Incorporation of Documents by Reference.
|
The following documents previously filed with
the SEC (File
No. 001-34473)
are hereby incorporated by reference:
|
(a)
|
our Annual Report on Form
10-K
for the fiscal year ended December 31, 2016 filed with the SEC on March 16, 2017 (the 2016 Annual Report);
|
|
(b)
|
our definitive proxy statement on Schedule 14A for the 2016 Annual Meeting of Shareholders filed with the SEC on April 22, 2016;
|
|
(c)
|
all other reports filed with the SEC pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act), since the end of the fiscal year covered by our 2016 Annual
Report; and
|
|
(d)
|
the description of our Common Stock contained in Exhibit 99.1 to our Annual Report on Form
10-K
for the fiscal year ended December 31, 2016 filed with the SEC on
March 16, 2017, including any amendments or reports filed for the purpose of updating such description.
|
All reports
and other documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities registered have been sold or which
deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents.
Under no circumstances will any information furnished under current items 2.02 or 7.01 of
Form 8-K
be deemed incorporated herein by reference unless such
Form 8-K
expressly provides to the contrary.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or
superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
EXPERTS
The consolidated financial statements of Omeros Corporation appearing in Omeros Corporations Annual Report (Form
10-K)
for the year ended December 31, 2016, and the effectiveness of Omeros Corporations internal control over financial reporting as of December 31, 2016, have been audited by Ernst & Young
LLP, independent registered public accounting firm, as set forth in their reports thereon (which contain an explanatory paragraph describing conditions that raise substantial doubt about the Registrants ability to continue as a going concern
as described in Note 1 to the consolidated financial statements) included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein in reliance upon such reports given on the authority of such firm
as experts in accounting and auditing.
Item 5.
|
Interests of Named Experts and Counsel.
|
The validity of the shares of Common Stock
being registered under this Registration Statement has been passed upon by Mr. Mark A. Metcalf, Associate General Counsel and Assistant Secretary of the Registrant. As of March 13, 2017, Mr. Metcalf held options under our 2008
Equity Incentive Plan to purchase up to 96,700 shares of Common Stock of the Registrant and was eligible to receive additional equity awards under such plan.
Reference is made to the Exhibit Index, which is incorporated herein by
reference.
A. The undersigned Registrant hereby undertakes: (1) to file, during
any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: (i) to include any prospectus required by Section 10(a)(3) of the Securities Act; (ii) to reflect in the prospectus any
facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this
Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum
aggregate offering price set forth in the Calculation of Registration Fee table in the effective registration statement; and (iii) to include any material information with respect to the plan of distribution not previously disclosed
in this Registration Statement or any material change to such information in this Registration Statement; provided, however, that clauses (1)(i) and (1)(ii) shall not apply if the information required to be included in a post-effective
amendment by those clauses is contained in periodic reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference into this Registration
Statement; (2) that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein and the offering of
such securities at that time shall be deemed to be the initial bona fide offering thereof; and (3) to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
B. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities
Act, each filing of the Registrants annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference into this Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
-2-
C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers, or controlling persons of the Registrant pursuant to the indemnification provisions summarized in Item 6 of the Form
S-8
filed on March 17, 2011 (File
No. 333-172905)
or otherwise, the Registrant has been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action,
suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
-3-
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on
Form S-8
and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of
Washington on March 16, 2017.
|
|
|
OMEROS CORPORATION
|
|
|
By:
|
|
/s/ Gregory A. Demopulos
|
|
|
Gregory A. Demopulos, M.D.
|
|
|
President, Chief Executive Officer and Chairman of the Board of Directors
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Gregory A. Demopulos, M.D.,
Michael A. Jacobsen and Marcia S. Kelbon, and each of them severally, as his true and lawful
attorney-in-fact
and agent, with full power of substitution and
resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same with all exhibits thereto, and other
documents in connection therewith, with the Securities and Exchange Commission, granting unto said
attorneys-in-fact
and agents, and each of them, full power and
authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact
and agents, or any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933 this Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
/s/ Gregory A. Demopulos
Gregory A. Demopulos, M.D.
|
|
President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)
|
|
March 16, 2017
|
|
|
|
/s/ Michael A. Jacobsen
Michael A. Jacobsen
|
|
Vice President, Finance, Chief Accounting Officer and Treasurer (Principal Financial and Accounting Officer)
|
|
March 16, 2017
|
|
|
|
/s/ Ray Aspiri
Ray Aspiri
|
|
Director
|
|
March 16, 2017
|
|
|
|
/s/ Thomas J. Cable
Thomas J. Cable
|
|
Director
|
|
March 16, 2017
|
|
|
|
/s/ Peter A. Demopulos
Peter A. Demopulos, M.D.
|
|
Director
|
|
March 16, 2017
|
|
|
|
/s/ Arnold C. Hanish
Arnold C. Hanish
|
|
Director
|
|
March 16, 2017
|
|
|
|
/s/ Leroy E. Hood
Leroy E. Hood, M.D., Ph.D.
|
|
Director
|
|
March 16, 2017
|
|
|
|
/s/ Rajiv Shah, M.D.
Rajiv Shah, M.D.
|
|
Director
|
|
March 16, 2017
|
-4-
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Exhibit Title
|
|
|
4.1
|
|
Amended and restated articles of incorporation of the Registrant (
incorporated by reference from Exhibit 3.1 to the Registrants Annual Report on Form
10-K
for the
fiscal year ended December
31, 2009, filed on March
31, 2010
).
|
|
|
4.2
|
|
Amended and restated bylaws of the Registrant (
incorporated by reference from Exhibit
3.2 to the Registrants Annual Report on Form
10-K
for the
fiscal year ended December
31, 2009, filed on March
31, 2010
).
|
|
|
4.3
|
|
2008 Equity Incentive Plan (
incorporated by reference from Exhibit 10.6 to the Registrants Annual Report on Form
10-K
for the fiscal year ended
December
31, 2016, filed on March
16, 2017
).
|
|
|
4.4
|
|
Form of Stock Option Award Agreement under the 2008 Equity Incentive Plan (to be used for awards granted on or after October 7, 2009) (
incorporated by reference from Exhibit 10.9 to Amendment No.
1 to the
Registrants Registration Statement on Form
S-1
(File No.
333-148572),
filed on April
1,
2008
).
|
|
|
4.5
|
|
Form of Stock Option Award Agreement under the 2008 Equity Incentive Plan (
incorporated by reference from Exhibit 10.2 to the Registrants Quarterly Report on Form
10-Q
for the
period ended September
30, 2013 (File No.
001-34475),
filed on November
7, 2013)
.
|
|
|
5.1
|
|
Opinion of Mark A. Metcalf, Associate General Counsel and Assistant Secretary.
|
|
|
23.1
|
|
Consent of Ernst & Young LLP (Independent Registered Public Accounting Firm).
|
|
|
23.2
|
|
Consent of Mark A. Metcalf (
included in Exhibit 5.1
).
|
|
|
24.1
|
|
Power of Attorney (
included as part of the signature page to this Registration Statement
).
|
-5-
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Aug 2024 to Sep 2024
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Sep 2023 to Sep 2024